GeoVax Provides Progress Report on Its Ebola Vaccine Program
Marketwired - Mon Jan 12, 8:01AM CST
GeoVax Labs, Inc. (OTCQB: GOVX), a biotechnology company developing innovative human vaccines using its unique vaccine delivery platform, today provided an update on its Ebola virus vaccine development program.
GeoVax's Chief Scientific Officer Invited to Present at Dubai Scientific Conference
Marketwired - Wed Dec 10, 1:00PM CST
GeoVax Labs, Inc. (OTCQB: GOVX), a biotechnology company developing innovative human vaccines using its novel DNA/MVA platform technology, today announced that its Chief Scientific Officer, Harriet L. Robinson, Ph.D. will participate as an invited speaker at the 8th Dubai International Conference for Medical Sciences to be held on December 15-17, 2014 in Dubai, United Arab Emirates. Dr. Robinson will give two presentations entitled "Working towards an Ebola vaccine" and "Clade B VLP-expressing HIV vaccine."
SEC suspends trading in certain Ebola-related stocks
Seeking Alpha - at Seeking Alpha - Thu Nov 20, 10:03AM CST
BCRX: 10.06 (-0.09), VSR: 3.42 (-0.02), TKMR: 21.45 (-0.22), NNVC: 2.97 (-0.05), INO: 6.80 (-0.15), CMRX: 40.16 (+0.08), APT: 2.88 (+0.17), HEB: 0.25 (+0.01), SRPT: 12.76 (+0.11), SMED: 4.75 (-0.04), PLX: 1.84 (-0.04), NLNK: 38.84 (+1.51), LAKE: 10.18 (+0.89), NSPH: 0.25 (unch)
Aethlon Medical up on successful Ebola treatment
Seeking Alpha - at Seeking Alpha - Mon Nov 17, 11:06AM CST
BCRX: 10.06 (-0.09), VSR: 3.42 (-0.02), TKMR: 21.45 (-0.22), NNVC: 2.97 (-0.05), INO: 6.80 (-0.15), CMRX: 40.16 (+0.08), APT: 2.88 (+0.17), HEB: 0.25 (+0.01), SRPT: 12.76 (+0.11), SMED: 4.75 (-0.04), NLNK: 38.84 (+1.51), PLX: 1.84 (-0.04), LAKE: 10.18 (+0.89), NSPH: 0.25 (unch)
GeoVax reports Q3 earnings
Seeking Alpha - at Seeking Alpha - Wed Nov 12, 9:22AM CST
GeoVax Reports 2014 Third Quarter Financial Results
ACCESSWIRE - Tue Nov 11, 8:01AM CST
ATLANTA, GA / ACCESSWIRE / November 11, 2014 / GeoVax Labs, Inc. (OTCQB: GOVX), a biotechnology company developing innovative human vaccines using its novel DNA/MVA platform technology, today announced financial results and recent developments for the three and nine months ended September 30, 2014.
GeoVax CEO Interviewed on the Fox Business Network
ACCESSWIRE - Thu Oct 30, 8:04AM CDT
Watch Robert McNally Discuss GeoVax's Ebola Vaccine Program
GeoVax Presents HIV Vaccine Clinical Trial Data
ACCESSWIRE - Wed Oct 29, 8:02AM CDT
Results of HIV Immunotherapy Vaccine Trial Presented at HIVR4P Conference
CDC issues new guidelines over Ebola
Seeking Alpha - at Seeking Alpha - Tue Oct 28, 3:10AM CDT
BCRX: 10.06 (-0.09), VSR: 3.42 (-0.02), TKMR: 21.45 (-0.22), NNVC: 2.97 (-0.05), INO: 6.80 (-0.15), CMRX: 40.16 (+0.08), APT: 2.88 (+0.17), HEB: 0.25 (+0.01), SRPT: 12.76 (+0.11), SMED: 4.75 (-0.04), NLNK: 38.84 (+1.51), PLX: 1.84 (-0.04), LAKE: 10.18 (+0.89), NSPH: 0.25 (unch)
Mali confirms first Ebola case
Seeking Alpha - at Seeking Alpha - Fri Oct 24, 3:48AM CDT
BCRX: 10.06 (-0.09), GOLD: 78.29 (-0.31), AU: 12.33 (+0.36), VSR: 3.42 (-0.02), TKMR: 21.45 (-0.22), NNVC: 2.97 (-0.05), INO: 6.80 (-0.15), CMRX: 40.16 (+0.08), APT: 2.88 (+0.17), HEB: 0.25 (+0.01), SRPT: 12.76 (+0.11), SMED: 4.75 (-0.04), NLNK: 38.84 (+1.51), PLX: 1.84 (-0.04), LAKE: 10.18 (+0.89), NSPH: 0.25 (unch)
NYC doctor tests positive for Ebola; futures slip
Seeking Alpha - at Seeking Alpha - Thu Oct 23, 8:57PM CDT
BCRX: 10.06 (-0.09), VSR: 3.42 (-0.02), TKMR: 21.45 (-0.22), NNVC: 2.97 (-0.05), INO: 6.80 (-0.15), SPY: 209.78 (+0.86), CMRX: 40.16 (+0.08), APT: 2.88 (+0.17), HEB: 0.25 (+0.01), SRPT: 12.76 (+0.11), SMED: 4.75 (-0.04), NLNK: 38.84 (+1.51), PLX: 1.84 (-0.04), LAKE: 10.18 (+0.89), NSPH: 0.25 (unch)
Ebola-stoked stocks rise
Seeking Alpha - at Seeking Alpha - Thu Oct 23, 2:49PM CDT
BCRX: 10.06 (-0.09), VSR: 3.42 (-0.02), TKMR: 21.45 (-0.22), NNVC: 2.97 (-0.05), INO: 6.80 (-0.15), CMRX: 40.16 (+0.08), APT: 2.88 (+0.17), HEB: 0.25 (+0.01), SRPT: 12.76 (+0.11), SMED: 4.75 (-0.04), NLNK: 38.84 (+1.51), PLX: 1.84 (-0.04), LAKE: 10.18 (+0.89), NSPH: 0.25 (unch)
GeoVax to Present HIV Vaccine Clinical Trial Data at HIVR4P Conference
ACCESSWIRE - Wed Oct 22, 8:18AM CDT
Results of HIV Immunotherapy Vaccine Trial (GV-TH-01) to be Presented
Obama appoints Ebola czar
Seeking Alpha - at Seeking Alpha - Fri Oct 17, 12:35PM CDT
BCRX: 10.06 (-0.09), VSR: 3.42 (-0.02), TKMR: 21.45 (-0.22), NNVC: 2.97 (-0.05), INO: 6.80 (-0.15), CMRX: 40.16 (+0.08), APT: 2.88 (+0.17), HEB: 0.25 (+0.01), SRPT: 12.76 (+0.11), SMED: 4.75 (-0.04), NLNK: 38.84 (+1.51), PLX: 1.84 (-0.04), LAKE: 10.18 (+0.89), IXJ: 104.21 (+0.61), IRY: 49.63 (+0.34), NSPH: 0.25 (unch)
Roller coaster ride continues for Ibio
Seeking Alpha - at Seeking Alpha - Thu Oct 16, 8:09AM CDT
BCRX: 10.06 (-0.09), VSR: 3.42 (-0.02), TKMR: 21.45 (-0.22), NNVC: 2.97 (-0.05), INO: 6.80 (-0.15), CMRX: 40.16 (+0.08), APT: 2.88 (+0.17), HEB: 0.25 (+0.01), SRPT: 12.76 (+0.11), SMED: 4.75 (-0.04), NLNK: 38.84 (+1.51), PLX: 1.84 (-0.04), LAKE: 10.18 (+0.89), IBIO: 0.90 (+0.36), NSPH: 0.25 (unch)
GeoVax warrant holders cash in on Ebola-stoked bullishness
Seeking Alpha - at Seeking Alpha - Wed Oct 15, 9:46AM CDT
Second Texas Ebola case stokes the index
Seeking Alpha - at Seeking Alpha - Wed Oct 15, 7:57AM CDT
BCRX: 10.06 (-0.09), VSR: 3.42 (-0.02), TKMR: 21.45 (-0.22), NNVC: 2.97 (-0.05), INO: 6.80 (-0.15), CMRX: 40.16 (+0.08), APT: 2.88 (+0.17), HEB: 0.25 (+0.01), SRPT: 12.76 (+0.11), SMED: 4.75 (-0.04), NLNK: 38.84 (+1.51), PLX: 1.84 (-0.04), LAKE: 10.18 (+0.89), IBIO: 0.90 (+0.36), NSPH: 0.25 (unch)